Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor panel

Cancer Chemotherapy and Pharmacology

Volumn 41, Issue 1, 1997, Pages 61-68

  Woo, Elizabeth S ^a   Monks, Anne ^c   Watkins, Simon C ^a   Wang, Angela S ^a   Lazo, John S ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

Chemotherapy; Immunofluorescence; Metals; Tumor cells

Indexed keywords

CADMIUM CHLORIDE; COPPER; GLUTATHIONE; LEAD; METAL; METALLOTHIONEIN; PLATINUM; THIOL; ZINC;

ARTICLE; BREAST CANCER; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; TISSUE SPECIFICITY; TUMOR CELL LINE;

CYTOPLASM; DRUG RESISTANCE; DRUG SCREENING ASSAYS, ANTITUMOR; FLUORESCENT ANTIBODY TECHNIQUE; GLUTATHIONE; HUMANS; METALLOTHIONEIN; METALS, HEAVY; NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031408620     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050708     Document Type: Article

References (34)

1. Alvarez M, Paull K, Monks A, Hose C, Lee JS, Weinstein J, Grever M, Bates S, Fojo T (1995) Generation of a drug resistance profile by quantification of mdr-1-P-glycoprotein in the cell lines of the National Cancer Institute anticancer drug screen. J Clin Invest 95: 2205
2. Banerjee D, Onosaka S, Cherian MG (1982) Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of rat liver and kidney. Toxicology 24: 95
3. Bauman JW, Liu J, Liu YP, Klaassen CD (1991) Increase in metallothionein produced by chemicals that induce oxidative stress. Toxicol Appl Pharmacol 110: 347
4. Boger DL, Patane MA, Jin Q, Kitos PA (1994) Design, synthesis and evaluation of bouvardin, deoxybouvardin and RA-I-XIV pharmacophore analogs. Bioorg Med Chem 2: 85
5. Britten RA, Green JA, Broughton C, Browning PG, White R, Warenius HM (1991) The relationship between nuclear glutathione levels and resistance to melphalan in human ovarian tumour cells. Biochem Pharmacol 41: 647
6. Brouwer M, Hoexum-Brouwer T, Cashon RE (1993) A putative glutathione-binding site in CdZn-metallothionein identified by equilibrium binding and molecular-modeling studies. J Biochem 294: 219
7. Chubatsu LS, Meneghini R (1993) Metallothionein protects DNA from oxidative damage. J Biochem 291: 193
8. Dalton T, Fu K, Enders GC, Palmiter RD, Andrews GK (1996) Analysis of the effects of overexpression of metallothionein-I in transgenic mice on the reproductive toxicology of cadmium. Environ Health Perspect 104: 68
9. Enger MD, Tesmer JG, Travis GL, Barham SS (1986) Clonal variation of cadmium response in human tumor cell lines. Am J Physiol 250: C256
10. Fitzsimmons SA, Workman P, Grever M, Paull K, Camalier R, Lewis AD (1996) Reductase enzyme expression across the National Cancer Institute tumor cell line panel: correlation with sensitivity to mitomycin C and E09. J Natl Cancer Inst 88: 259
11. Hamer DH (1986) Metallothionein. Annu Rev Biochem 55: 913
12. Jahroudi N, Foster R, Price-Haughey J, Beitel G, Gedamu L (1990) Cell-type specific and differential regulation of the human metallothionein genes. J Biol Chem 265: 6506
13. Kimball SR, Chen SJ, Risica R, Jefferson LS, Leure-duPree AE (1995) Effects of zinc deficiency on protein synthesis and expression of specific mRNAs in rat liver. Met Clin Exp 44: 126
14. Kondo Y, Kuo S-M, Lazo JS (1994) Interleukin β mediated metallothionein induction and cytoprotection against cadmium and cis-diamminedichloroplatinum. J Pharmacol Exp Ther 270: 1313
15. Kondo Y, Kuo S-M, Watkins SC, Lazo JS (1995) Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines. Cancer Res 55: 474
16. Kondo Y, Woo E, Michalska AE, Choo AC, Lazo JS (1995) Metallothionein null cells have increased sensitivity to anticancer drugs. Cancer Res 55: 2021
17. Kuo S-M, Kondo Y, DeFilippo JM, Ernstoff MS, Bahnson RR, Lazo JS (1994) Subcellular localization of metallothionein IIA in human bladder tumor cells using a novel epitope-specific antiserum. Toxicol Appl Pharmacol 125: 104
18. Lazo JS, Pitt BR (1995) Metallothioneins and cell death by anticancer drugs. In: Cho AK, Blaschke TF, Loh HH, Way JL (eds) Annual review of pharmacology and toxicology. Annual Reviews, Palo Alto, pp 635
19. Lee JS, Paull K, Alvarez M, Hose C, Monks A, Grever M, Fojo AT, Bates S (1994) Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol Pharmacol 46: 627
20. Leyshon-Sorland K, Morkrid L, Rugstrad HE (1993) Metallothionein: a protein conferring resistance in vitro to tumor necrosis factor. Cancer Res 53: 4874
21. Masters BA, Kelly EJ, Quaife CJ, Brinster RL, Palmiter RD (1993) Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci USA 91: 584
22. Michalska AE, Choo KHA (1993) Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc Natl Acad Sci USA 90: 8088
23. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 83: 757
24. Nagel WW, Vallee BL (1995) Cell cycle regulation of metallothionein in human colonic cancer cells. Proc Natl Acad Sci USA 92: 579
25. Nartey NO, Banerjee D, Cherian MG (1987) Immunochemical localization of metallothionein in cell nucleus and cytoplasm of fetal human liver and kidney and its changes during development. Pathology 19: 233
26. Palmiter RD, Sandgren EP, Koeller DM, Brinster RL (1993) Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol Cell Biol 13: 5266
27. Paull KD, Shoemaker RH, Hodes L, Monks A, Scudiero DA, Rubenstein K, Plowman J, Boyd MR (1989) Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J Natl Cancer Inst 81: 1088
28. Rodriguez-Fonseca C, Amils R, Garrett RA (1995) Fine structure of the peptidyl transferase centre on 23 S-like rRNAs deduced from chemical probing of antibiotic-ribosome complexes. J Mol Biol 247: 224
29. Schwarz MA, Lazo JS, Yalowich JC, Reynolds I, Kagan VE, Tyurin V, Kim T-M, Watkins SC, Pitt BR (1994) Cytoplasmic metallothionein overexpression protects NIH 3T3 cells from tert-butyl hydroperoxide toxicity. J Biol Chem 269: 15238
30. Schwarz MA, Lazo JS, Yalowich JC, Allen WP, Whitmore M, Bergonia HA, Tzeng E, Billiar TR, Robbins PD, Lancaster JR Jr, Pitt BR (1995) Metallothionein protects against the cylotoxic and DNA damaging effects of nitric oxide. Proc Natl Acad Sci USA 92: 4452
31. Thomas M, Nicklee T, Hedley DW (1995) Differential effects of depleting agents on cytoplasmic and nuclear non-protein stilphydryls: a fluorescence image cytometry study. Br J Cancer 72: 45
32. Tsujikawa K, Imai T, Kakutani M, Kayamori Y, Mimura T, Otaki N, Kimura M, Fukuyama R, Shimizu N (1991) Localization of metallothionein in nuclei of growing primary cultured adult rat hepatocytes. FEBS Lett 283: 239
33. Woo ES, Kondo Y, Watkins SC, Hoyt DG, Lazo JS (1996) Nucleophilic distribution of metallothionein in human tumor cells. Exp Cell Res 224: 365
34. Zeng J, Vallee BL, Kaji JHR (1991) Zinc transfer from transcription factor IIIA fingers to thioneine clusters. Proc Natl Acad Sci USA 88: 9984